GMR M1 FORTE

About

GMR M1 FORTE represents a fixed-dose combination medication specifically engineered for the comprehensive management of type 2 diabetes mellitus. This formulation typically integrates Glimepiride, a potent sulfonylurea, with Metformin, a well-established biguanide. Glimepiride exerts its therapeutic effect by stimulating the beta cells within the pancreas to augment insulin secretion, thereby facilitating the uptake of glucose by peripheral tissues and lowering circulating blood glucose levels. Metformin operates through multiple mechanisms: it significantly decreases hepatic glucose production (gluconeogenesis), reduces the absorption of glucose from the intestinal tract, and crucially enhances insulin sensitivity in peripheral tissues.

This powerful dual mechanism of action provides robust glycemic control, assisting patients in achieving and maintaining target blood sugar levels and substantially mitigating the long-term risks associated with diabetes-related complications, particularly when lifestyle interventions alone prove insufficient.

Uses

• Management of type 2 diabetes mellitus.
• Improvement of glycemic control.
• When diet and exercise are insufficient.
• As an adjunct to lifestyle modifications.

Directions For Use

Take with meals to reduce gastrointestinal side effects, or as directed by your physician. Swallow tablets whole.

Benefits

• Effectively lowers blood sugar levels.
• Improves insulin sensitivity.
• Reduces hepatic glucose production.
• Helps prevent long-term diabetes complications.
• Convenient combination therapy.
• Supports overall metabolic health.

Side Effects

• Hypoglycemia (low blood sugar)
• Nausea
• Diarrhea
• Abdominal pain
• Vomiting
• Metallic taste in mouth
• Headache
• Dizziness
• Weight gain (less common with metformin)
• Skin rash
• Lactic acidosis (rare, serious)
• Vitamin B12 deficiency (long-term use)

Safety Measures

• Alcohol - Avoid excessive alcohol consumption as it can increase the risk of hypoglycemia and lactic acidosis, especially with metformin.
• Pregnancy - Generally not recommended during pregnancy; insulin is usually preferred. Consult a doctor immediately if pregnant or planning pregnancy.
• Breastfeeding - Not recommended during breastfeeding as both components can pass into breast milk. Consult a doctor.
• Liver - Use with extreme caution or avoid in patients with severe liver impairment due to increased risk of lactic acidosis.
• Kidney - Contraindicated in patients with severe kidney impairment (eGFR <30 mL/min) due to increased risk of lactic acidosis. Dosage adjustment needed for moderate impairment.
• Lung - Use with caution in severe lung conditions that may lead to hypoxia, as this can increase the risk of lactic acidosis.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.